Head-to-head · WeighScore
Direct Meds vs ElleS
By GLP-1 ScorecardUpdated
Score comparison
Direct Meds has the higher recorded score — 77.6/100 to 56/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.
Before you choose
Before comparing the headline prices, the Direct Meds review and the ElleS review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Direct Meds vs Fitstry and ElleS vs Fitstry compare each of them with another graded program, and the list of alternatives to Direct Meds ranks the programs closest to Direct Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Direct Meds | ElleS |
|---|---|---|
| WeighScore | 77.6/100 | 56/100 |
| Grade | C+ | C |
| Site position | #33 | #455 |
| Semaglutide | $249/30 days sublingual · $297/mo injectable | $269/mo monthly plan ($2,327 for 12 months; compounded) |
| Tirzepatide | $299/30 days sublingual · $399/mo injectable | $359/mo monthly plan ($3,497 for 12 months; compounded) |
| Coverage | Not publicly listed | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #33 · C+
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Strengths
- Injection and sublingual preparations have separately published prices
- Pricing page advertises medication, evaluation, supplies, shipping and nurse access
- Both semaglutide and tirzepatide are listed
- Checked semaglutide campaign states $147 initially, then $297 monthly
What to consider
- Compounded preparations are not FDA-approved products or assumed equivalent across routes
- No-subscription FAQ wording conflicts with the agreement's 30-day recurring charges
- Renewal cancellation requires 48-hour notice; initial-order cancellation has a separate conditional 24-hour window
- Assigned prescribing practice, dispensing pharmacy and selected longer-plan total need confirmation
- Checked campaign excludes Mississippi and Louisiana; confirm state eligibility
Strengths
- Compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus microdose options
- Packages bundle the telehealth visit, medication, and shipping; Registered Dietitian support included
- Full legal suite published — Terms, Privacy Policy, Privacy Practices, and Medical Consent
- Broad menu: also TRT, HRT (estradiol), sexual health, hair loss, and longevity (sermorelin, NAD+)
What to consider
- Pricing not shown publicly — products and costs appear only after the intake flow
- Sold as 3- and 6-month packages rather than simple monthly plans
- Compounding pharmacy partner not named ('made in licensed US facilities')
- LegitScript certification was not documented on the public pages reviewed
Featured provider
Direct Meds
Direct Meds scores 77.6/100 (C+). Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.